Drug Side Effects
Search
OVARIAN CLEAR CELL CARCINOMA
OVARIAN CLEAR CELL CARCINOMA
was reported 39 times
OVARIAN CLEAR CELL CARCINOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Echinocandin Antifungal [EPC]
1
0.0001
1
Vascular Endothelial Growth Factor Inhibitor [EPC]
14
0.0001
2
Sphingosine 1-phosphate Receptor Modulator [EPC]
1
0.0001
3
Programmed Death Receptor-1 Blocking Antibody [EPC]
6
0.0001
4
Microtubule Inhibitor [EPC]
9
0.0001
5
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
1
0.0000
6
Topoisomerase Inhibitor [EPC]
3
0.0000
7
Provitamin D2 Compound [EPC]
1
0.0000
8
Platinum-based Drug [EPC]
9
0.0000
9
Parathyroid Hormone-Related Peptide Analog [EPC]
1
0.0000
10
Estrogen [EPC]
3
0.0000
11
Interferon beta [EPC]
3
0.0000
12
Alkylating Drug [EPC]
3
0.0000
13
Integrin Receptor Antagonist [EPC]
1
0.0000
14
P2Y12 Platelet Inhibitor [EPC]
1
0.0000
15
Progestin [EPC]
2
0.0000
16
Kinase Inhibitor [EPC]
3
0.0000
17
Factor Xa Inhibitor [EPC]
1
0.0000
18
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
19
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
20
GLP-1 Receptor Agonist [EPC]
1
0.0000
21
Tumor Necrosis Factor Blocker [EPC]
2
0.0000